Share to Facebook
Bolt Threads, a maker of biomaterials including a key ingredient for skincare inspired by spider silk, plans to go public in a SPAC deal that values the one-time unicorn at $250 million.
“We wanted to zig when others zag,” cofounder and CEO Dan Widmaier told Forbes. “If the expectation is that things
→ Continue reading at Forbes - Startups